Ovarian Reserve in Patients With Psoriasis

Completed

• Conditions: Anti Mullerian Hormone; Ovarian Reserve; Psoriasis
• Interventions: Other: Hormone panel

• Registration Number: NCT03492632
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve. This study aims to measure serum hormones including FSH,LH,E2,PRL and AMH (indicators of ovarian reserve) in women with and without psoriasis.

Detailed Description

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Almost 75% of patients are diagnosed before the age of 40. There is also increased evidence on autoimmune disease and their link to premature ovarian failure.Ovarian reserve is important for the reproductive period. The measurements of serum hormones including follicle stimulating hormone (FSH),luteinizing hormone (LH),prolactin (PRL), estradiol (E2) and anti-mullerian hormone (AMH) will give us an idea about the ovarian reserve. The investigators aim is to measure ovarian reserve parameters in patients newly diagnosed with psoriasis and to compare them to healthy controls. Serum FSH,LH,E2,PRL and AMH will be measured on the 3rd day of the cycle.The serum hormone levels will be compared between women with psoriasis and women without psoriasis

Study Timeline

• Study Start: 2017-10-25
• Study First Submitted: 2018-04-03
• Study First Submitted QC: 2018-04-03
• Study First Posted: 2018-04-10
• Primary Completion: 2018-06-30
• Status Verified: 2018-07
• Study Completion: 2018-07-03
• Last Update Submitted: 2018-07-03
• Last Update Posted: 2018-07-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

• Reproductive age group women: 18-40 years
• Women diagnosed with psoriasis (case group)
• Women without psoriasis (control group)

Read More

Exclusion Criteria

• Women with PCOS (polycystic ovary syndrome)
• history of ovarian surgery
• Body mass index (BMI) over 30
• Women with other autoimmune diseases including Hashitomo thyroiditis
• Women with family history of premature ovarian insufficiency (POI)
• Women with infertility
• Psoriasis using systemic drugs including steroids and immunosuppressive therapy.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Women with Psoriasis	Hormone panel	Reproductive age women newly diagnosed with psoriasis
Women without Psoriasis	Hormone panel	Reproductive age women without psoriasis to serve as control

Primary Outcome Measures

Name	Time	Method
to compare serum AMH levels between the two groups	1 day	Serum AMH levels will be measured (using ELISA) and compared between the two groups

Trial Locations

Locations (1)

Kanuni Sultan Suleyman Research and Training Hospital; 🇹🇷 Istanbul, Turkey